Ledger.Open graph →

SEC Form D · Amendment · filed April 19, 2022

Triana Biomedicines, Inc

Offering

$85.1M

Sold

$42.6M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WALTHAM, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Richard Y. Bilotti · Piedmont, CADirector Christopher O'Donnel · Waltham, MADirector Tom B. Mccandless · Vancouver, British Columbia, CanadaDirector Jonathan Lamb · New York, NYDirector Patrick Trojer · Waltham, MAExec · Director Simon Read · Waltham, MADirector Joshua Resnick · Waltham, MADirector Christopher O'Donnel · Waltham, MADirector Jigar Raythatha · Waltham, MADirector Ronald Rosenfarb · CAROLINA, Puerto RicoDirector Grady J. Gaynor · Carmel, INDirector Nathan Mcgill · Columbus, OHExec · Director Milind Deshpande · Waltham, MADirector Peter Rozenauers · New York, NYDirector Jay A. Brammer · Carmel, INDirector Michael Esposito · Redondo Beach, CADirector Shelley Chu · Waltham, MADirector Oskar Lewnowski · New York, NYExec · Director Jigar Raythatha · Waltham, MADirector Ethan Y. Huynh · Piedmont, CADirector Andrew P. Walrath · Schenectady, NYDirector David Grayzel · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗